Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04550741
Other study ID # UF 9797
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 10, 2022
Est. completion date May 2025

Study information

Verified date September 2023
Source University Hospital, Montpellier
Contact Maurice HAYOT, MD, PhD
Phone +33 467 335 908
Email m-hayot@chu-montpellier.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic obstructive pulmonary disease (COPD) is a public health problem: high prevalence; increasing morbidity and mortality; impact on health costs. Pulmonary rehabilitation (PR) is a multidisciplinary intervention combining exercise training, therapeutic education, psychosocial and behavioral interventions. Its effects are beneficial in the short and medium terms but are limited in time, between 6 and 12 months, for patients who do not pursue regular physical activity (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life. (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life.


Description:

Exclusion criteria: - Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause). - Patients with significant and unstable cardiovascular disease. - Inability to understand and/or answer questionnaires. - Refusal to use a smartphone or digital device. - Unable to access an internet connection at home. Analysis: - The main analysis will be the univariate intention-to-treat analysis of the primary outcome. - Secondary analyzes will include: - Analysis with intention to treat secondary endpoints. - Multivariate analysis of the efficiency criteria. - Univariate and multivariate medico - economic cost - utility analyzes, with their respective sensitivity analyzes. Protocol: This prospective, randomized study with two parallel arms, controlled against standard chronic care will be multicentric and open. - Patients included will be patients diagnosed with COPD who are on RR for four weeks in one of the three centers participating in the study. - Participation in the study will be offered after verification of the eligibility criteria, during the 3rd week of the stay. - The information note will then be provided to them. - After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms: - - Experimental group of 100 patients using the M-Réhab BPCO telerehabilitation solution. The solution will be provided during the fourth and final week of RR's stay during which patients will be trained to use all of the solution's features. Patients will carry out the entire post-rehabilitation using the remote rehabilitation solution and will benefit from medical assessments by teleconsultation at 1, 3, 6 and 12 months as well as assessments at 3, 6 and 12 months by filling. electronic auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home. - Control group of 100 patients following usual standard chronic care. Patients will receive during the last week of stay in the center, the usual advice to continue physical activity and nutritional advice at home. The evaluations at 3, 6 and 12 months will be done by electronic filling of auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home. The duration of the inclusions is 18 months and the follow-up will be carried out over 12 months.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 2025
Est. primary completion date October 1, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years to 78 Years
Eligibility Inclusion Criteria: - Patients diagnosed with COPD according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) creteria. - Presence of an incompletely reversible obstructive ventilatory disorder defined by a report VEMS / CVF lower than the lower limit of normal post-bronchodilator. - Patient on RR for four weeks in respiratory rehabilitation center. - Aged between 40 and 78 years. Exclusion Criteria: - Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause). - Patients with significant and unstable cardiovascular disease. - Inability to understand and/or answer questionnaires. - Refusal to use a smartphone or digital device. - Unable to access an internet connection at home.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
telerehabilitation
After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms: Experimental and Control group

Locations

Country Name City State
France Centre hopsitalier universitaire de Montpellier Montpellier Occitanie
France Clinique du Souffle Osséja

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life of chronic obstructive pulmonary disease patients after a 1-year téléherabilitaion versus standard care program, after an initial short-term pulmonary rehabilitation program Quality of life assessed by the Saint Georges Respiratory Questionnaire. Three scores are calculated for the components: Symptoms; Activities; Impacts. A Total SCORE is also calculated.
The minimum significant difference is 4 points.
12 months
Secondary Pre-intentional variables Perceived risk: questionnaire focused on respiratory disease and conditioned by absence of adoption of physical activity behavior.
Expectation of conséquences: questionnaire of the expected effects of Physical activity on physical health and psychological well-being.
Self-efficacy: questionnaire relating to their perceived ability to perform the quantity of physical activity recommended by healthcare professionals.
Intentions: determination and realization of physical activity behavior in the next months.
baseline
Secondary Post-intentional variables planning: by a Questionnaire relating to the anticipation of the conditions to realize physical activity.
self-efficacy with regard to barriers: questionnaire relating to their perceived ability to perform physical activity recommended despite the difficulties encountered.
Social support:questionnaire relating to the behavior of the entourage habits: questionnaire on automatic nature of physical activity behavior.
6 months
Secondary Physical Activity behaviors. Measured by the International Physical Activity Questionnaire as a continuous variable (MET minutes a week). MET minutes represent the amount of energy expended carrying out physical activity.
walking consider to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS.
12 months
Secondary Predictive model of physical activity behavior Test a predictive model of physical activity behavior at 12 months in each of the two arm groups. At 12 months
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy